We Support New Ideas

Our mission:
to fund new ideas at their inception

The Society’s independently judged, peer-reviewed research grants are highly valued by researchers and considered important and prestigious within the scientific community.

The Society has funded research projects by most of Canada’s top glaucoma researchers – doctors and scientists interested in finding new treatments and in preventing blindness from glaucoma. These highly respected researchers are recognized across Canada and internationally.

Their research includes:

  • seeking to protect good nerve cells in the eye and repair damaged ones
  • searching for genes related to glaucoma
  • improving blood flow to the eye, and
  • making glaucoma surgery easier for the patient.

80% of funds raised go directly to researchers

Sound governance, a volunteer board, and low administration costs ensure that more than 80% of funds raised by the Society go directly to Canadian researchers.

The Glaucoma Research Society of Canada is the only Canadian non-profit organization solely dedicated to funding glaucoma research. Since 1989, it has raised more than two million dollars in support of 150 research projects. The Society funds 10 to 15% of all independent glaucoma research in Canada.

2015 Research Grants

  • Identification of the genetic basis of PG in Mennonite families using whole exome sequencing – Dr. Michael A. Walter, Dr. Ordan Lehmann, University of Alberta Edmonton, AB
  • Relationship between gaze behaviour and mobility deficits in individuals – Dr. Dan Marigold, Simon Fraser University Burnaby, BC
  • A prospective study to compare the effect of continuous positive airways pressure versus a mandibular advancement oral appliance on intraocular pressure in patients with obstructive sleep apnea and open angle glaucoma – Dr. Yvonne M. Buys, Dr. Mariana Cabrera Perez, Toronto Western Hospital, Toronto, ON
  • Self-induced motion in people with glaucoma (2ND RENEWAL) – Dr. Martin J. Steinbach, Toronto Western Research Institute Toronto, ON
  • Designing a new delivery system for glaucoma medication (SUBMITTED IN FRENCH) – Dr. Elodie Boisselier, Dr. Vincent Pernet, Dr. Beatrice Des Marchais, Laval University, Laval, Quebec
  • Combination therapies for the treatment of glaucoma – Dr. Catherine Tsilfidis, Ottawa Hospital Research Institute, Ottawa, ON
  • Novel latency-associated peptide based ligand traps in the treatment of glaucoma – Dr. Sanjoy K. Gupta, Dr. Neelam Khaper, Northern Ontario School of Medicine Lakehead University, Thunder Bay, ON
  • Portable perimeter – Dr. Moshe Eizenman, Dr. Jonathan Rose, University of Toronto, Toronto, ON
  • Sub-conjunctival bevacizumab for the rescue of blebs – Dr. Catherine Birt, Dr. Christoph Kranemann, Sunnybrook Health Science Centre, Toronto, ON
  • Investigating the role of Neogenin on TNF- a expression and neurodegeneration – Dr. Nardos Tassew, Dr. Philippe Monnier, Toronto Western Research Institute, Toronto, ON
  • Determination of the neuroprotective potential of TCAP-1 in an in vitro model of glaucoma – Dr. Joanne E. Nash, Dr. David Lovejoy, University of Toronto, Scarborough, ON
  • Mapping the outflow pathways from the eye with photoacoustic technology – Dr. Yeni Yucel, Dr. Neeru Gupta, St. Michael’s Hospital, Toronto, ON
  • Neuroprotective strategies in glaucoma: cannabinoid modulation of RGC calcium dynamics – Dr. William H. Baldridge, Dr. Melanie E. M. Kelly, Elizabeth Cairns, BSc PhD Candidate, Dalhousie University Halifax, NS
  • Efficacy of PGC-1a induction on retinal ganglion cells (RENEWAL) – Dr. Jeremy Sivak, Toronto Western Research Institute, Toronto, ON
  • The effect of oral doxycycline on intraocular pressure in patients with ocular surface disease – Dr. Gdih A. M. Gdih, Dr. Raageen Kanjee, Dr. Stephen Brodovsky, Dr. Tenley N. Bower, University of Manitoba Winnipeg, MB
at work in the lab Dr. Alexander Ball’s 2009 Lab Group

Your donations have funded numerous scientists who have gained international respect and reputations in advancing research into glaucoma.

The next decade should see some important breakthroughs including methods to maintain and possibly even repair damaged optic nerves in glaucoma.

Your support is essential to continue this valuable and much needed research.

Research Grant Applications

Researchers into glaucoma from across Canada apply annually for funding. Independent peers review the applications under the guidance of the Scientific Advisory Committee of renowned ophthalmologists and scientists from across the country. The Committee makes funding recommendations to the Society's Board of Directors.

Applying for a Grant